论文部分内容阅读
[目的]观察三伏灸辨证分型联合西药治疗支气管哮喘疗效。[方法]使用随机平行对照方法,将92例住院患者按抛硬币法简单随机分为两组。对照组46例多索茶碱0.5g+9%生理盐水250m L,1次/d,静滴;布地奈德,0.1mg/次,2次/d。治疗组46例三伏灸,肺气虚选大椎、双侧肺俞;脾气虚选大椎、双侧肺俞、双侧脾俞;肾气虚选大椎、双侧肺俞、双侧肾俞,与传统“三伏日”中初、中、末伏治疗,穴位上放置3cm×2.5cm生姜,厚度0.3cm,姜片上放置圆锥形艾柱,艾柱底面直径为1cm,重约1.5g,连续3壮,至取穴部位局部皮肤潮红,后敷贴三伏贴,三伏贴的药物配方:延胡索、白芥子、甘遂、细辛,药量比例:2:2:1:1。磨粉,生理盐水调糊,敷贴穴位,防过敏胶布固定,感觉局部灼热刺痛钻透皮下时去除;西药治疗同对照组。连续治疗14d为1疗程。观测临床症状、FEV1、FVC、不良反应。治疗1疗程,判定疗效。[结果]治疗组显效31例,有效13例,无效2例,总有效率95.65%;对照组显效25例,有效10例,无效11例,总有效率76.09%;治疗组疗效优于对照组(P<0.01)。FEV1、FVC两组均有改善(P<0.01),治疗组改善优于对照组(P<0.01)。[结论]三伏灸辨证分型联合西药治疗支气管哮喘疗效满意,无严重不良反应,值得推广。
[Objective] To observe the curative effect of three-volt moxibustion syndrome differentiation combined with Western medicine on bronchial asthma. [Methods] Using randomized parallel control method, 92 inpatients were randomly divided into two groups according to the coin-tossing method. Control group, 46 cases of doxofylline 0.5g + 9% saline 250m L, 1 times / d, intravenous; budesonide, 0.1mg / times, 2 times / d. In the treatment group, 46 cases were treated with three-point moxibustion, Dazhui with lung deficiency and bilateral Feishu with spleen deficiency; Dazhui with bilateral spleen deficiency and bilateral spleen and Yu both sides with spleen deficiency; Dazhui, bilateral Feishu and bilateral Shensu with kidney deficiency, The “three volts day” in early, middle and late V treatment, the acupuncture points placed 3cm × 2.5cm ginger, thickness 0.3cm, ginger placed conical Ai Zhu, Ai column bottom diameter of 1cm, weighing about 1.5g, for 3 consecutive years , To acupoints local skin flushing, after the application paste Sanva paste, three-dimensional paste the drug formula: Corydalis, Mustard Seed, Kansui, Asarum, dose ratio: 2: 2: 1: Powder, saline paste, apply the acupuncture points, anti-allergy tape fixed, feeling the local burning when piercing burns to remove; Western medicine treatment with the control group. Continuous treatment 14d for a course of treatment. Observed clinical symptoms, FEV1, FVC, adverse reactions. Treatment of a course of treatment to determine the efficacy. [Results] In the treatment group, 31 cases were markedly effective, 13 cases were effective, 2 cases were ineffective, and the total effective rate was 95.65%. In the control group, 25 cases were markedly effective, 10 cases effective and 11 ineffective, with a total effective rate of 76.09% (P <0.01). FEV1 and FVC improved in both groups (P <0.01), the treatment group improved better than the control group (P <0.01). [Conclusion] The therapeutic effect of Sanwei Moxibustion on syndrome differentiation combined with Western medicine in treating bronchial asthma is satisfactory and no serious adverse reactions are worthy of promotion.